Seaport Diagnostics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 10

Seaport Diagnostics General Information

Description

Developer of deoxyribonucleic acid test kits designed to treat genetically inherited diseases. The company's kits leverage biological science and technology to provide access to information about genes and offer genetic testing and personalized vitamins, enabling users to make proactive and personalized choices that may impact well-being.

Contact Information

Formerly Known As
Orig3n
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 27 Drydock Avenue
  • 3rd Floor
  • Boston, MA 02210
  • United States
+1 (800)
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Laboratory Services (Healthcare)
Vertical(s)
Corporate Office
  • 27 Drydock Avenue
  • 3rd Floor
  • Boston, MA 02210
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Seaport Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private Completed Generating Revenue
6. Later Stage VC 09-Sep-2020 Completed Generating Revenue
5. Debt - PPP 15-Apr-2020 Completed Generating Revenue
4. Early Stage VC (Series B) 11-Jul-2018 Completed Generating Revenue
3. Early Stage VC (Series A2) 27-Jun-2017 Completed Generating Revenue
2. Early Stage VC (Series A) 16-Dec-2015 $12.5M $15.6M Completed Generating Revenue
1. Early Stage VC (Series 1) 05-Feb-2015 $3.14M $3.14M Completed Generating Revenue
To view Seaport Diagnostics’s complete valuation and funding history, request access »

Seaport Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A2
Series A 11,372,211 $0.000100 6% $1.1 $1.1 1x $1.1 13.49%
Series 1 7,498,225 $0.000100 6% $0.42 $0.42 1x $0.42 8.89%
To view Seaport Diagnostics’s complete cap table history, request access »

Seaport Diagnostics Patents

Seaport Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-190053-S Transitional graphical user interface Active 07-Aug-2018
WO-2020009920-A1 Foldable box for genetic assessment kit Inactive 06-Jul-2018
AU-2019232732-A1 Ipsc-derived cell compositions, and related systems and methods for cartilage repair Inactive 06-Mar-2018
CA-3093370-A1 Ipsc-derived cell compositions, and related systems and methods for cartilage repair Inactive 06-Mar-2018
EP-3761996-A1 Ipsc-derived cell compositions, and related systems and methods for cartilage repair Inactive 06-Mar-2018 A61K35/32
To view Seaport Diagnostics’s complete patent history, request access »

Seaport Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Seaport Diagnostics Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
Sekhmet Ventures Venture Capital Minority
Woori Venture Partners Venture Capital Minority
Alexandria Venture Investments Venture Capital Minority
Haitong International Securities Group Investment Bank Minority
MMIC Investment Venture Capital Minority
You’re viewing 5 of 10 investors. Get the full list »

Seaport Diagnostics Acquisitions (2)

Seaport Diagnostics’s most recent deal was a Merger/Acquisition with Telomere Diagnostics. The deal was made on 01-Aug-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Telomere Diagnostics 01-Aug-2020 Merger/Acquisition Discovery Tools (Healthcare)
Interleukin Genetics 22-Nov-2017 Merger/Acquisition Laboratory Services (Healthcare)
To view Seaport Diagnostics’s complete acquisitions history, request access »

Seaport Diagnostics FAQs

  • When was Seaport Diagnostics founded?

    Seaport Diagnostics was founded in 2014.

  • Where is Seaport Diagnostics headquartered?

    Seaport Diagnostics is headquartered in Boston, MA.

  • What is the size of Seaport Diagnostics?

    Seaport Diagnostics has 14 total employees.

  • What industry is Seaport Diagnostics in?

    Seaport Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Seaport Diagnostics a private or public company?

    Seaport Diagnostics is a Private company.

  • What is Seaport Diagnostics’s current revenue?

    The current revenue for Seaport Diagnostics is .

  • How much funding has Seaport Diagnostics raised over time?

    Seaport Diagnostics has raised $112M.

  • Who are Seaport Diagnostics’s investors?

    Sekhmet Ventures, Woori Venture Partners, Alexandria Venture Investments, Haitong International Securities Group, and MMIC Investment are 5 of 10 investors who have invested in Seaport Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process